Last reviewed · How we verify

Sole local anesthetic

Nanjing Medical University · FDA-approved active Small molecule

A local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in localized tissues.

A local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in localized tissues. Used for Local anesthesia for minor surgical procedures, Topical anesthesia for pain relief.

At a glance

Generic nameSole local anesthetic
Also known asRopivacaine, Naropin
SponsorNanjing Medical University
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Local anesthetics work by inhibiting voltage-gated sodium channels on nerve fibers, preventing depolarization and action potential propagation. This reversibly blocks conduction of sensory (particularly pain) and motor nerve impulses in the area of application, producing localized anesthesia without systemic effects when used appropriately.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: